These observations suggest that GPx1 acts as a tumour suppressor to prevent BC development but that its anti-oxidant properties may be particularly crucial to block the development of certain subtypes of BC, and eGPx1 has the potential of becoming a biomarker for BC risk [35]. Here, GPX1 is linked to neoplasm.